Mark Zetin, MD: Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients

Name: Mark Zetin, MD: Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients
SKU: 2901
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 39 No. 1 Articles Tags: adjuvant-treatment, antidepressant, cara-t-hoepner, clinical-response, comorbidity, depression, lynda-bjornson, mark-zetin, medworks-media, psychopharmacology-bulletin, remission

Description

Mark Zetin, MD: Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients

Description

Mark Zetin, MD

EVIDENCE-BASED MEDICINE

Rational Antidepressant Selection: Applying Evidence Based Medicine to Complex Real-World Patients

Mark Zetin, MD, Cara T. Hoepner, RN, and Lynda Bjornson, PhD

Clozapine Factors in Schizophrenia by Takefumi Suzuki

Zonisamide for Bipolar Depression by Deborah Dauphinais

What Mood Symptoms may be most Difficult to Rate?

Clozapine Related Suicidal Obsession by Branka Aukst-Margetic

Mark Zetin, MD: Rational Antidepressant Selection: Applying Evidence-Based Medicine to Complex Real-World Patients

Description

Mark Zetin, MD

EVIDENCE-BASED MEDICINE

Rational Antidepressant Selection: Applying Evidence Based Medicine to Complex Real-World Patients

Mark Zetin, MD, Cara T. Hoepner, RN, and Lynda Bjornson, PhD

Related products

Clozapine Factors in Schizophrenia by Takefumi Suzuki

Zonisamide for Bipolar Depression by Deborah Dauphinais

What Mood Symptoms may be most Difficult to Rate?

Clozapine Related Suicidal Obsession by Branka Aukst-Margetic